[English] 日本語
Yorodumi- PDB-9f2g: Crystal structure of SARS-CoV-2 N-protein C-terminal domain (apo form) -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9f2g | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Crystal structure of SARS-CoV-2 N-protein C-terminal domain (apo form) | |||||||||
Components | Nucleoprotein | |||||||||
Keywords | VIRAL PROTEIN / CTD / SARS-CoV-2 nucleocapsid / COVID-19 / riluzole / benzothiazols | |||||||||
| Function / homology | Function and homology information: / response to host immune response / viral RNA genome packaging / negative regulation of interferon-beta production / Maturation of nucleoprotein / poly(U) RNA binding / intracellular membraneless organelle / positive regulation of NLRP3 inflammasome complex assembly / MHC class I protein binding / CD28 dependent PI3K/Akt signaling ...: / response to host immune response / viral RNA genome packaging / negative regulation of interferon-beta production / Maturation of nucleoprotein / poly(U) RNA binding / intracellular membraneless organelle / positive regulation of NLRP3 inflammasome complex assembly / MHC class I protein binding / CD28 dependent PI3K/Akt signaling / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / protein sequestering activity / VEGFR2 mediated vascular permeability / molecular condensate scaffold activity / NOD1/2 Signaling Pathway / TAK1-dependent IKK and NF-kappa-B activation / DDX58/IFIH1-mediated induction of interferon-alpha/beta / MHC class I protein complex / RNA stem-loop binding / Interleukin-1 signaling / Interferon alpha/beta signaling / viral capsid / PIP3 activates AKT signaling / viral nucleocapsid / Transcription of SARS-CoV-2 sgRNAs / host cell endoplasmic reticulum-Golgi intermediate compartment / Translation of Structural Proteins / Virion Assembly and Release / host extracellular space / host cell Golgi apparatus / Induction of Cell-Cell Fusion / Attachment and Entry / host cell perinuclear region of cytoplasm / ribonucleoprotein complex / SARS-CoV-2 activates/modulates innate and adaptive immune responses / protein homodimerization activity / RNA binding / extracellular region / identical protein binding / cytoplasm Similarity search - Function | |||||||||
| Biological species | ![]() | |||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.57 Å | |||||||||
Authors | Marquez-Monino, M.A. / Gonzalez, B. / Perez-Canadillas, J.M. | |||||||||
| Funding support | Spain, 2items
| |||||||||
Citation | Journal: Structure / Year: 2025Title: The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity. Authors: Marquez-Monino, M.A. / Santiveri, C.M. / de Leon, P. / Camero, S. / Campos-Olivas, R. / Jimenez, M.A. / Saiz, M. / Gonzalez, B. / Perez-Canadillas, J.M. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9f2g.cif.gz | 210 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9f2g.ent.gz | 168.7 KB | Display | PDB format |
| PDBx/mmJSON format | 9f2g.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9f2g_validation.pdf.gz | 502.3 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9f2g_full_validation.pdf.gz | 507.4 KB | Display | |
| Data in XML | 9f2g_validation.xml.gz | 52.9 KB | Display | |
| Data in CIF | 9f2g_validation.cif.gz | 71.9 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/f2/9f2g ftp://data.pdbj.org/pub/pdb/validation_reports/f2/9f2g | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9f2hC ![]() 9f2iC C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 | ![]()
| ||||||||
| 4 | ![]()
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 12528.094 Da / Num. of mol.: 8 Source method: isolated from a genetically manipulated source Details: "C-terminal domain. Initial GS are expression tags." Source: (gene. exp.) ![]() Plasmid: pET28-txAHEV / Production host: ![]() #2: Chemical | ChemComp-GOL / #3: Chemical | ChemComp-SO4 / #4: Water | ChemComp-HOH / | Has ligand of interest | N | Has protein modification | N | |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.19 Å3/Da / Density % sol: 43.84 % / Description: Rods |
|---|---|
| Crystal grow | Temperature: 291 K / Method: vapor diffusion, sitting drop / pH: 8.5 Details: PEG 3350 37%, 0.1 M Tris pH 8.5, 50 mM ammonium sulfate and 1 mM InsP6. Protein:precipitant ratio 1:1. Protein concentration: 16.5 mg/ml. Protein buffer: 20 mM Tris pH 8.0 and 150 mM NaCl. |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: ALBA / Beamline: XALOC / Wavelength: 0.97926 Å |
| Detector | Type: DECTRIS PILATUS 6M / Detector: PIXEL / Date: May 22, 2021 / Details: KB mirrors, rectangular beam shape |
| Radiation | Monochromator: Channel-cut Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.97926 Å / Relative weight: 1 |
| Reflection | Resolution: 1.57→48.42 Å / Num. obs: 123141 / % possible obs: 97.4 % / Redundancy: 6.4 % / Biso Wilson estimate: 19.806 Å2 / CC1/2: 0.999 / Rpim(I) all: 0.019 / Net I/σ(I): 21.2 |
| Reflection shell | Resolution: 1.57→1.6 Å / Redundancy: 4.7 % / Mean I/σ(I) obs: 1.2 / Num. unique obs: 4598 / CC1/2: 0.647 / Rpim(I) all: 0.531 / % possible all: 74.1 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENT / Resolution: 1.57→48.42 Å / Cor.coef. Fo:Fc: 0.967 / Cor.coef. Fo:Fc free: 0.948 / SU B: 2.105 / SU ML: 0.072 / Cross valid method: THROUGHOUT / ESU R: 0.096 / ESU R Free: 0.098 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 23.748 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: 1 / Resolution: 1.57→48.42 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




X-RAY DIFFRACTION
Spain, 2items
Citation

PDBj











